Paid Clinical Trials in Tulsa, OK
As of June 2026, 178 paid clinical trials are recruiting in Tulsa, Oklahoma. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tulsa offers studies at sites including Oklahoma Cancer Specialists and Research Institute-Tulsa for conditions such as Heart Failure, Breast Cancer, Depression, Endometrial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tulsa
Trials by drug in Tulsa
Filter results
178 clinical trials
↓ Download CSVA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Empowered Relief® for Cancer Survivors With Chronic Pain
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
NORM-HF Pivotal Study
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study of Buntanetap in Participants With PD
The ArtixASCEND Study
LIFU Mechanisms for PTSD in Healthcare Workers
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Decoding Emotional Dynamics in Bipolar Disorder
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
About research studies in Tulsa
Tulsa has approximately 178 recruiting research studies across a wide range of therapeutic areas. Oklahoma hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Tulsa
Researchers run research studies in Tulsa, OK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Oklahoma Cancer Specialists and Research Institute-Tulsa | Anatomic Stage II Breast Cancer AJCC v8, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 16 |
| Laureate Institute for Brain Research | Depression, Anorexia Nervosa, Anxiety | 13 |
| Oklahoma Cancer Specialists and Research Institute, LLC | Cervical Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Cervical Carcinoma | 9 |
| DelRicht Research | Chronic Pain, Osteoarthritis, Knee, Acute Gout Flare | 7 |
| Oklahoma Heart Institute | Aortic Valve Stenosis, Abdominal Aortic Aneurysm, Aortic Stenosis, Calcific | 7 |
| The Movement Disorder Clinic of Oklahoma | Lewy Body Dementia Psychosis, Parkinson Disease, Deep Brain Stimulation | 6 |
| Natalie Warren Bryant Cancer Center at Saint Francis | Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | 5 |
| Central States Research | Alzheimer Disease, Acute Treatment of Migraine, Dementia | 5 |
| Oklahoma Cancer Specialists and Research Institute | Breast Cancer, Endometrial Cancer, Melanoma | 5 |
| Ascension St. John | Ischemic Stroke, Stroke, Acute Stroke | 4 |
| Saint Francis Hospital | Acute Lower Limb Arterial Occlusion, Atrial Fibrillation, Cardiovascular Diseases | 4 |
| Essential Medical Research | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 4 |
| Saint Francis Children's Hospital | Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia | 3 |
| Tulsa Retina Consultants | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 3 |
| Ascension St. John Clinical Research Institute | Peripheral Vascular Diseases, Symptomatic Hypertrophic Cardiomyopathy (HCM) | 2 |
| Ascension St. John Medical Center | Atrial Fibrillation, Coagulation Disorder, Intracerebral Hemorrhage | 2 |
| DelRicht Research - Tulsa | Gout, Tophaceous Gout | 2 |
| GSK Investigational Site | Chickenpox, Neoplasms, Head and Neck | 2 |
| Hillcrest Medical Center | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 2 |
| Options Health Research | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| St. John Medical Center | Intracerebral Hemorrhage, Atrial Fibrillation | 2 |
| Stephenson Cancer Center- Tulsa | Breast Cancer, Lymphoma, Pancreas Cancer | 2 |
| University of Oklahoma - Schusterman Center | Pain, Discrimination, Racial, Smoking (Tobacco) Addiction | 2 |
| University of Oklahoma Health Campus | Prediabetes, Smoking, Cigarette | 2 |
| University of Oklahoma Schusterman Center - Tulsa | Alcohol Drinking, Binge Drinking, Chronic Pain Due to Cancer | 2 |
Active & Upcoming Studies in Tulsa (2026)
Recruiting trials in Tulsa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- Empowered Relief® for Cancer Survivors With Chronic Pain · University of Oklahoma
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · Phase 3 · Merck Sharp & Dohme LLC
Neurology & pain (22 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Mental health & behavior (13 active studies)
- LIFU Mechanisms for PTSD in Healthcare Workers · Laureate Institute for Brain Research, Inc.
- Decoding Emotional Dynamics in Bipolar Disorder · Laureate Institute for Brain Research, Inc.
Cardiovascular (12 active studies)
- NORM-HF Pivotal Study · Foundry Innovation & Research 1, Limited (FIRE1)
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) · Supira Medical
Diabetes & metabolic (4 active studies)
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Eye & vision (4 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Vaccines (3 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations · Phase 4 · ModernaTX, Inc.
HIV / STI (1 active study)
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Tulsa
- Heart Failure (5 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Depression (4 active studies). Depression studies test rapid-acting antidepressants including ketamine derivatives, psilocybin-assisted therapy, and neuromodulation approaches.
- Endometrial Cancer (4 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Alzheimer Disease (3 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Aortic Valve Stenosis (3 active studies). Recruiting Aortic Valve Stenosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Tulsa
- Laureate Institute for Brain Research, Inc.
- University of Oklahoma
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in Oklahoma are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Oklahoma research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Tulsa. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Tulsa
Hipa.ai aggregates every recruiting study in Tulsa from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Tulsa?
There are approximately 178 recruiting clinical trials in Tulsa, Oklahoma listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tulsa pay participants?
Most recruiting trials in Tulsa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tulsa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tulsa?
The most common conditions under active study in Tulsa include Heart Failure (5), Breast Cancer (4), Depression (4), Endometrial Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tulsa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tulsa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tulsa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tulsa?
Recruiting research sites in Tulsa include Oklahoma Cancer Specialists and Research Institute-Tulsa, Laureate Institute for Brain Research, Oklahoma Cancer Specialists and Research Institute, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tulsa right now?
The largest active categories in Tulsa are Cancer & tumors (49), Neurology & pain (22), Mental health & behavior (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.